Legal Issues and BPCI Act
The legal issues pertaining to the follow-on-biologics and biosimilars are one of the most aspects that requires an open discussion. Before the actual advent of biosimilars to the market legal issues have risen in numbers in their developmental stages. Renowned organizations have filed cases against each other two claim their rights and for other legal allegations related to the products. This track is dedicated to discussion of all such cases which has been argued in the court of law.
By 2002, the FDA had approved 36 new biologics, followed by 37 more in 2003, another 40 in 2004 and 39 more in 2005. By 2006, the leading category of biologic treatment, the red blood cell enhancer recombinant erythropoietin (EPO), generated $14 billion in sales revenues, or 40 percent more than the best-selling traditional pharmaceutical, Lipitor. More than 300 therapeutic antibodies currently are in clinical development and trials, compared to just 13 that already are widely available due to legal issues.
Related Conference of Legal Issues and BPCI Act
November 25-26, 2024
10th International Conference on Antimicrobials & Antibiotic Resistance
Vancouver, Canada
November 26-27, 2024
3rd World Conference on Pharma Industry and Medical Devices
Zurich, Switzerland
November 28-29, 2024
41st International Conference on Drug Discovery and Drug delivery system
Paris, France
November 28-29, 2024
16th International Conference on Biosimilars and Pharma Innovations
Bali, Indonesia
December 12-13, 2024
12th International Conference and Exhibition on Natural Products and Medicinal Plants Research
Rome, Italy
March 13-14, 2025
8th International on Pharmacy and Pharmaceutical Conference
Prague, Czech Republic
April 07-08, 2025
4th International Conference and Expo on Pharmaceutics & Novel Drug Delivery Systems
Vancouver, Canada
May 05-06, 2025
17th International Conference on Pharmaceutical Education and Practice
Vancouver, Canada
June 02-03, 2025
31st International Conference on Advanced Clinical Research and Clinical Trials
Amsterdam, Netherlands
June 10-11, 2025
24th International Conference on Medicinal and Pharmaceutical Chemistry
Vancouver, Canada
June 10-11, 2025
7th International Conference and Exhibition on Pharmaceutical Development and Technology
Vancouver, Canada
June 16-17, 2025
18th International Conference and Exhibition on Pharmacovigilance & Drug Safety
Frankfurt, Germany
June 23-24, 2025
25th World Congress on Pharmaceutical Sciences and Innovations in Pharma Industry
Paris, France
September 23-24, 2025
10th International Conference on Future Pharma and Innovations
Amsterdam, Netherlands
October 22-23, 2025
7th European Conference on Advance Clinical Trials and Research
Aix-en-Provence, France
Legal Issues and BPCI Act Conference Speakers
Recommended Sessions
- BCS and IVIVC Based Biowaivers
- Biological Medicine
- Biopharmaceutical Informatics
- Biosimilars Approval to Biogenerics in Clinical Practice
- Biosimilars Development in Markets
- Biosimilars Market and Cost Analysis
- Biosimilars Research Pipeline
- Challenges in Biosimilars Pharmacovigilance
- Chemical and Analytical Strategies for Biosimilars
- Consequences of Brexit on Biosimilars
- Current Agency Expectations for Approval for Biosimilars
- Current Challenges in Developing Biosimilars
- Drug Delivery and Development
- Emerging Biosimilars in Therapeutics
- Formulation Strategies for Follow-on Biologics
- Globalization of Biosimilars
- Innovative Clinical Approach in Biosimilars
- Intellectual Property Rights
- Legal Issues and BPCI Act
- Monoclonal Antibody Biosimilars
- Regulatory Updates on Biosimilars
- USFDA Approved Biosimilars
Related Journals
Are you interested in
- 3D Printing of Drugs - PHARMA CONFERENCE-2025 (Czech Republic)
- Active Pharmaceutical Ingredients - MedTech-2024 (Switzerland)
- Acupuncture - Natural Products 2024 (Italy)
- Adaptive Trial Models in Research - Clinical Trials Congress-2025 (France)
- Advanced Analytical Techniques in Drug Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Advanced Drug Delivery System - BIOSIMILARS-2024 (Indonesia)
- Advanced Drug Delivery Systems - PHARMA CONFERENCE-2025 (Czech Republic)
- Advancements in drug delivery systems - Pharmaceutica-2025 (Canada)
- Advancements in Drug Discovery - Pharmacology-2024 (France)
- Advancements in Pharmacovigilance - Clinical Trials Congress-2025 (France)
- Advances in Cardiovascular Drug Discovery - Cardiovascular-2025 (France)
- Advances in Controlled Release Formulations - Pharmaceutica-2025 (Canada)
- Advances in Drug Discovery - Clinical Trials Congress-2025 (France)
- Advances in Pharmaceutical Packaging - PHARMACEUTICAL SCIENCES 2025 (France)
- Advances in Vaccine Delivery - Drug Delivery-2024 (France)
- Alternative Medicine and Complementary Medicine - Natural Products 2024 (Italy)
- Analysis and Quality Control for Pharmaceuticals - Drug Safety 2024 (France)
- Analytical Biotechnology - Biotech-2025 (France)
- Analytical Chemistry - PHARMAKON 2025 (Spain)
- Analytical strategies for pharmaceutical products - MedTech-2024 (Switzerland)
- Antibiotic Prophylaxis - Antibiotics Resistance 2024 (Canada)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics Resistance 2024 (Canada)
- Antibiotic-resistant Bacterial infections - Antibiotics Resistance 2024 (Canada)
- Antibiotics - Antibiotics Resistance 2024 (Canada)
- Antibiotics - PHARMAKON 2025 (Spain)
- Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2024 (Canada)
- Antimicrobial Peptides - Antibiotics Resistance 2024 (Canada)
- Antimicrobial Therapy - Antibiotics Resistance 2024 (Canada)
- Application of Pharmacology in Medical Science - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Applied Medicinal Chemistry - PHARMAKON 2025 (Spain)
- Applied Microbiology - Biotech-2025 (France)
- Artificial Intelligence (AI) - Personalizedmedicine-2024 (Switzerland)
- Artificial Intelligence and Machine Learning in Drug Delivery Optimization - Pharmaceutica-2025 (Canada)
- Artificial Intelligence and Machine Learning in Pharmaceutical Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Artificial Intelligence in Drug Discovery - PHARMA CONFERENCE-2025 (Czech Republic)
- BCS and IVIVC Based Biowaivers - BIOSIMILARS-2024 (Indonesia)
- BCS and IVIVC Based Biowaivers - BIOSIMILARS-2024 (Indonesia)
- BCS and IVIVC Based Biowaivers - Eurobiosimilars 2025 (France)
- Big data analytics and Pharma - Future Pharma 2025 (Netherlands)
- Bio Molecular Dynamics - Biotech-2025 (France)
- Bio-Organic Chemistry - PHARMAKON 2025 (Spain)
- Bioequivalence and Bioavailability - MedTech-2024 (Switzerland)
- Bioethics and Regulatory Compliance - Clinical-Trials-2024 (Canada)
- Bioinformatics - Pharma Europe 2025 (Italy)
- Bioisosteres - PHARMAKON 2025 (Spain)
- Biological Drugs in Autoimmune Diseases - PHARMAKON 2025 (Spain)
- Biological Medicine - BIOSIMILARS-2024 (Indonesia)
- Biological Medicine - Eurobiosimilars 2025 (France)
- Biologics and Biosimilars - Pharmaceutica-2025 (Canada)
- Biologics and Biosimilars - PHARMA CONFERENCE-2025 (Czech Republic)
- Biomarker Discovery in Drug Development - Clinical Trials Congress-2025 (France)
- Biomarkers - Personalizedmedicine-2024 (Switzerland)
- Biomarkers in Cardiovascular Disease and Drug Response - Cardiovascular-2025 (France)
- Biomaterials and Biodegradable Polymers in Drug Delivery - Drug Delivery-2024 (France)
- Biopharmaceutical Formulation Development - Drug Delivery-2024 (France)
- Biopharmaceutical Informatics - BIOSIMILARS-2024 (Indonesia)
- Biopharmaceutical Informatics - Eurobiosimilars 2025 (France)
- Biopharmaceuticals - Biotech-2025 (France)
- Biopharmaceuticals and Biotechnology - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Biopharmaceuticals, Biomolecules, and Therapeutics - Drug Safety 2024 (France)
- Biopharmaceutics and Drug Disposition - Pharmaceutica-2025 (Canada)
- Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Biosimilars - Biotech-2025 (France)
- Biosimilars Approval to Biogenerics in Clinical Practice - Eurobiosimilars 2025 (France)
- Biosimilars Development in Markets - Eurobiosimilars 2025 (France)
- Biosimilars Market and Cost Analysis - Eurobiosimilars 2025 (France)
- Biosimilars Research Pipeline - Eurobiosimilars 2025 (France)
- Biotechnology and Biopharmaceuticals - PHARMA CONFERENCE-2025 (Czech Republic)
- Biotechnology and Microbiology in Pharmaceuticals - Drug Safety 2024 (France)
- Biotechnology in Pharmacotherapy - Pharmacology-2024 (France)
- Cancer Biotechnology - Biotech-2025 (France)
- Cancer Clinical Research Progress - Clinical Trials Congress-2025 (France)
- Cardiac Arrhythmias and Pharmacotherapy - Cardiovascular-2025 (France)
- Cardio protective Agents: Mechanisms and Applications - Cardiovascular-2025 (France)
- Cardiovascular Drug Safety and Toxicology - Cardiovascular-2025 (France)
- Cardiovascular Pharmacology in Special Populations - Cardiovascular-2025 (France)
- Cellular Targeting and subcellular Delivery - Drug Safety 2024 (France)
- Challenges and Future Innovations of Traditional Medicine - Natural Products 2024 (Italy)
- Challenges in Biosimilars Pharmacovigilance - Eurobiosimilars 2025 (France)
- Challenges in Drug Formulation and Stability - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Challenges In Pharmaceutical Formulations - Pharmatech 2025 (Canada)
- Chemical and Analytical Strategies for Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Chemical and Analytical Strategies for Biosimilars - Eurobiosimilars 2025 (France)
- Chemical Synthesis and Catalysis - PHARMAKON 2025 (Spain)
- Chemo genomics - PHARMAKON 2025 (Spain)
- Chromatography & Separation Techniques - PHARMAKON 2025 (Spain)
- Chronic Disease Management and Palliative Care - NURSING PHARMACOLOGY 2024 (Netherlands)
- Clinical and Hospital Pharmacy - PHARMACEUTICAL SCIENCES 2025 (France)
- Clinical and Hospital Pharmacy - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Clinical and Hospital Pharmacy - PHARMA CONFERENCE-2025 (Czech Republic)
- Clinical and Hospital Pharmacy - Future Pharma 2025 (Netherlands)
- Clinical and Medical Case Reports - Pharma Europe 2025 (Italy)
- Clinical Data & Analytics Strategies - Clinical Trials Congress-2025 (France)
- Clinical Data Management and Analytics - Clinical-Trials-2024 (Canada)
- Clinical Operations & Project Management - Clinical-Trials-2024 (Canada)
- Clinical Pharmacology & Receptor Therapy - Clinical Trials Congress-2025 (France)
- Clinical Pharmacy - Pharma Europe 2025 (Italy)
- Clinical Pharmacy and Pharmacy Practices - MedTech-2024 (Switzerland)
- Clinical Pharmacy and Therapeutics - PHARMACEUTICAL SCIENCES 2025 (France)
- Clinical Research & Clinical Trials - PHARMA CONFERENCE-2025 (Czech Republic)
- Clinical Research & Clinical Trials: Academic Perspective - Clinical-Trials-2024 (Canada)
- Clinical Research and Drug Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Clinical Supply Management - Clinical-Trials-2024 (Canada)
- Clinical Trial Auditing Innovations - Clinical Trials Congress-2025 (France)
- Clinical Trial Efficiency Factors - Clinical Trials Congress-2025 (France)
- Clinical Trial Forecasting, Budgeting and Contracting - Clinical-Trials-2024 (Canada)
- Clinical Trial Site Selection and Management - Clinical-Trials-2024 (Canada)
- Clinical Trials - Personalizedmedicine-2024 (Switzerland)
- Clinical Trials - Clinical Trials Congress-2025 (France)
- Clinical Trials & Safety Monitoring - Clinical Trials Congress-2025 (France)
- Clinical trials and Pharmacovigilance - MedTech-2024 (Switzerland)
- Clinical Trials of Antibiotics - Antibiotics Resistance 2024 (Canada)
- Clinical Trials on different Diseases - Clinical-Trials-2024 (Canada)
- Computational Chemistry and Molecular Modeling - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Computer Assisted Drug Design - Biotech-2025 (France)
- Computer-Aided Drug Design - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Consequences of Brexit on Biosimilars - BIOSIMILARS-2024 (Indonesia)
- Consequences of Brexit on Biosimilars - Eurobiosimilars 2025 (France)
- COVID-19 and Drug Repurposing - PHARMA CONFERENCE-2025 (Czech Republic)
- CRO, Sponsorship & Outsourcing for Clinical Trials - Clinical-Trials-2024 (Canada)
- Crude Drugs and Plant Products - Natural Products 2024 (Italy)
- Current Agency Expectations for Approval for Biosimilars - Eurobiosimilars 2025 (France)
- Current Challenges in Developing Biosimilars - Eurobiosimilars 2025 (France)
- Current research in antibiotic resistance - Antibiotics Resistance 2024 (Canada)
- Cutting-edge Imaging Research - Clinical Trials Congress-2025 (France)
- Data Analytics - Personalizedmedicine-2024 (Switzerland)
- Decentralized Trial Models - Clinical Trials Congress-2025 (France)
- Delivery of Medicine via Inhalation - Drug Safety 2024 (France)
- Developing Alternatives to Antibiotics - Antibiotics Resistance 2024 (Canada)
- Development and Production of Pharmaceutical Products - Drug Safety 2024 (France)
- Diagnostics & Medical Devices - Biotech-2025 (France)
- Digital Health - Personalizedmedicine-2024 (Switzerland)
- Digital Health and Pharmacology - Pharmacology-2024 (France)
- Digital Health and Telemedicine - PHARMA CONFERENCE-2025 (Czech Republic)
- Digital Marketing in Pharma Industry - Future Pharma 2025 (Netherlands)
- Digital Pharma - BIOSIMILARS-2024 (Indonesia)
- Digital Pharma - PHARMACEUTICAL SCIENCES 2025 (France)
- Digital Pharma - Pharmatech 2025 (Canada)
- Disease Prevention - Personalizedmedicine-2024 (Switzerland)
- Drug Delivery & Blood-Brain Barrier - Clinical Trials Congress-2025 (France)
- Drug Delivery and Development - Eurobiosimilars 2025 (France)
- Drug Delivery and Gene Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery Challenges in Neurological Disorders - Drug Delivery-2024 (France)
- Drug Delivery for Cardiovascular Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery in Cancer Therapy - Pharmaceutica-2025 (Canada)
- Drug Delivery in Infectious Diseases - Pharmaceutica-2025 (Canada)
- Drug Delivery Strategies for Cancer Therapy - Drug Delivery-2024 (France)
- Drug Delivery Systems - Pharma Europe 2025 (Italy)
- Drug Delivery Techniques - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Drug Delivery Technology - BIOSIMILARS-2024 (Indonesia)
- Drug Delivery Technology and Vaccine Design - Drug Safety 2024 (France)
- Drug Delivery Using Peptides and Proteins - Drug Safety 2024 (France)
- Drug Design, Discovery and Development - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Drug Development - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Development - PHARMAKON 2025 (Spain)
- Drug Discovery - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Discovery and Development - Clinical-Trials-2024 (Canada)
- Drug Discovery and Development - Future Pharma 2025 (Netherlands)
- Drug Discovery and Development - Pharmatech 2025 (Canada)
- Drug discovery and NCEs - MedTech-2024 (Switzerland)
- Drug Discovery and Novel Delivery Technologies - Antibiotics Resistance 2024 (Canada)
- Drug Formulation - BIOSIMILARS-2024 (Indonesia)
- Drug Formulation - PHARMACEUTICAL SCIENCES 2025 (France)
- Drug Metabolism - PHARMAKON 2025 (Spain)
- Drug Product Manufacturing - Pharmatech 2025 (Canada)
- Drug Regulations - Pharma Europe 2025 (Italy)
- Drug Repurposing and Drug Rediscovery - Pharmacology-2024 (France)
- Drug Repurposing and Drug Rediscovery - Drug Delivery-2024 (France)
- Drug Repurposing in Cardiovascular Medicine - Cardiovascular-2025 (France)
- Drug Research and Evaluation - Drug Safety 2024 (France)
- Drug Safety - Drug Safety 2024 (France)
- Drug Targeting and Design - Pharmaceutica-2025 (Canada)
- Drug Targeting and Design - Pharmatech 2025 (Canada)
- Electronic Health Records (EHRs) - Personalizedmedicine-2024 (Switzerland)
- Emerging Antithrombotic Therapies - Cardiovascular-2025 (France)
- Emerging Biosimilars in Therapeutics - Eurobiosimilars 2025 (France)
- Emerging Technologies in Drug Discovery - Drug Delivery-2024 (France)
- Encapsulated Drugs - BIOSIMILARS-2024 (Indonesia)
- Endothelial Nitric Oxide and Cardiovascular Health - Cardiovascular-2025 (France)
- Enrollment Planning and Patient Recruitment - Clinical-Trials-2024 (Canada)
- Entrepreneurs Investment Meet - PHARMACEUTICAL SCIENCES 2025 (France)
- Environmental Catalysis and Green Chemistry - PHARMAKON 2025 (Spain)
- Epigenetic Therapies in Cancer - PHARMA CONFERENCE-2025 (Czech Republic)
- Ethno pharmacy - PHARMAKON 2025 (Spain)
- Formulation Strategies for Follow-on Biologics - Eurobiosimilars 2025 (France)
- Formulations and NNDS - MedTech-2024 (Switzerland)
- Future of Clinical Trials and Technology Innovations - Clinical-Trials-2024 (Canada)
- Future Perspectives in Drug Discovery and Delivery - Drug Delivery-2024 (France)
- Gene Therapy and RNA-based Therapeutics - Drug Delivery-2024 (France)
- Generics versus Big Pharma - PHARMACEUTICAL SCIENCES 2025 (France)
- Genetic Testing - Personalizedmedicine-2024 (Switzerland)
- Genomics - Personalizedmedicine-2024 (Switzerland)
- Genotoxicity - PHARMAKON 2025 (Spain)
- Geriatric Nursing and Age-Related Care - NURSING PHARMACOLOGY 2024 (Netherlands)
- Global Health Challenges and Healthcare Equity - NURSING PHARMACOLOGY 2024 (Netherlands)
- Globalization of Biosimilars - Eurobiosimilars 2025 (France)
- Globalization of Clinical Trials - Clinical-Trials-2024 (Canada)
- Globalized Pharma Sector - PHARMACEUTICAL SCIENCES 2025 (France)
- Green and Community Pharmacy - Future Pharma 2025 (Netherlands)
- Green Chemistry in Pharmaceutical Development - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Health Equity - Personalizedmedicine-2024 (Switzerland)
- Healthcare Policy and Management - NURSING PHARMACOLOGY 2024 (Netherlands)
- Herbal Medicine - Natural Products 2024 (Italy)
- Hereditary Angioedema Research - Clinical Trials Congress-2025 (France)
- Homeopathic and Ayurvedic Medicines - Natural Products 2024 (Italy)
- Hydrogel-Based Delivery for Diabetes - PHARMA CONFERENCE-2025 (Czech Republic)
- Immunology & Vaccines - Antibiotics Resistance 2024 (Canada)
- Immunopharmacology of Autoimmune Disorders - Pharmacology-2024 (France)
- Industrial and Physical Pharmacy - PHARMACEUTICAL SCIENCES 2025 (France)
- Industrial Bioproceses for Drug Production and Development - Biotech-2025 (France)
- Industrial Pharmacy - Pharma Europe 2025 (Italy)
- Industrial Pharmacy and Physical pharmacy - Future Pharma 2025 (Netherlands)
- Infectious Diseases - Antibiotics Resistance 2024 (Canada)
- Innovations in clinical study designs - Clinical-Trials-2024 (Canada)
- Innovations in Heart Failure Pharmacotherapy - Cardiovascular-2025 (France)
- Innovations in Nursing Technology and Informatics - NURSING PHARMACOLOGY 2024 (Netherlands)
- Innovations in Oral Drug Delivery Systems - Drug Delivery-2024 (France)
- Innovations In Pharmaceutical Technology - Pharmatech 2025 (Canada)
- Innovative Clinical Approach in Biosimilars - Eurobiosimilars 2025 (France)
- Innovative Drug Design and Discovery - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Integrative Medicine and Holistic Healthcare - NURSING PHARMACOLOGY 2024 (Netherlands)
- Intellectual Property Rights - BIOSIMILARS-2024 (Indonesia)
- Intellectual Property Rights - Eurobiosimilars 2025 (France)
- Intellectual property rights and regulatory issues - Drug Safety 2024 (France)
- Legal Issues and BPCI Act - Eurobiosimilars 2025 (France)
- Lifestyle Medicine - Personalizedmedicine-2024 (Switzerland)
- Lipids and Cholesterol Management in Cardiovascular Disease - Cardiovascular-2025 (France)
- Marine Natural Products - Natural Products 2024 (Italy)
- Mass Spectrometry - PHARMAKON 2025 (Spain)
- Mechanism and Evolution of Antibiotic Resistance - Antibiotics Resistance 2024 (Canada)
- Medical and Clinical Case Reports - Clinical-Trials-2024 (Canada)
- Medical Imaging in Clinical Research - Clinical-Trials-2024 (Canada)
- Medicinal Chemistry - Natural Products 2024 (Italy)
- Medicinal Chemistry - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Medicinal Chemistry and Targeted Therapies - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Medicinal Chemistry: Physical Properties and Drug Design - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Medicinal Plant Research - Natural Products 2024 (Italy)
- Medicinal Plants as Anti-Cancer Drugs - Natural Products 2024 (Italy)
- Medico Marketing - PHARMACEUTICAL SCIENCES 2025 (France)
- Mental Health and Psychiatric Nursing - NURSING PHARMACOLOGY 2024 (Netherlands)
- Micro Organisms in Recent Drug Discovery - Antibiotics Resistance 2024 (Canada)
- Microbial & Environmental Biotechnology - Biotech-2025 (France)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics Resistance 2024 (Canada)
- Modern drug delivery techniques - Drug Safety 2024 (France)
- Molecualr Biotechnology - Biotech-2025 (France)
- Molecular and Cellular Pharmacology - PHARMAKON 2025 (Spain)
- Molecular Mechanisms of Cardiovascular Pharmacology - Cardiovascular-2025 (France)
- Monoclonal Antibody Biosimilars - Eurobiosimilars 2025 (France)
- Nano medicine and Nanotechnology in Drug Delivery - Pharmaceutica-2025 (Canada)
- Nanomedicine and Nano Technology - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Nanomedicine in Cardiovascular Pharmacology - Cardiovascular-2025 (France)
- Nanotechnology Applications in Drug Delivery - Drug Delivery-2024 (France)
- Nanotechnology in Drug Delivery - Pharma Europe 2025 (Italy)
- Nanotechnology in Drug Delivery Systems - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Nanotechnology in Drug Discovery - Clinical Trials Congress-2025 (France)
- Natural Products - Natural Products 2024 (Italy)
- Natural Products and Traditional Medicine - PHARMA CONFERENCE-2025 (Czech Republic)
- Natural Products Chemistry - Natural Products 2024 (Italy)
- Natural Products Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- New Advances in Drug Delivery Systems - Drug Safety 2024 (France)
- New antibiotics and non-antibiotic approaches - Antibiotics Resistance 2024 (Canada)
- New Sources and Approaches to Natural Products - Natural Products 2024 (Italy)
- Next-Gen Drug Design Techniques - Clinical Trials Congress-2025 (France)
- NMR in Rational Drug Design - PHARMAKON 2025 (Spain)
- Novel Drug Delivery Systems - Future Pharma 2025 (Netherlands)
- Novel Drug Delivery Systems, Biomarkers & Drug Targets - MedTech-2024 (Switzerland)
- Novel Drug Delivery Technologies - Drug Delivery-2024 (France)
- Novel Drug Delivery Technologies - Pharmaceutica-2025 (Canada)
- Novel Target Drugs to the Treatment of Cancer - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Novel Targets in Hypertension Therapy - Cardiovascular-2025 (France)
- Nursing Education and Practice - NURSING PHARMACOLOGY 2024 (Netherlands)
- Nursing Leadership and Professional Development - NURSING PHARMACOLOGY 2024 (Netherlands)
- Nursing Research and Evidence-Based Practice - NURSING PHARMACOLOGY 2024 (Netherlands)
- Nutraceuticals and Functional Medicine - Natural Products 2024 (Italy)
- Organic Chemistry and Inorganic Chemistry - PHARMAKON 2025 (Spain)
- Organic Chemistry in Pharmaceuticals - Clinical Trials Congress-2025 (France)
- Patient Safety and Quality Improvement - NURSING PHARMACOLOGY 2024 (Netherlands)
- Patient-Cantered Care - Personalizedmedicine-2024 (Switzerland)
- Patient-Centric Clinical Trials - Clinical-Trials-2024 (Canada)
- Peptide and Protein Drug Delivery - Pharmaceutica-2025 (Canada)
- Personalized Healthcare - Personalizedmedicine-2024 (Switzerland)
- Personalized Medicine in Cardiovascular Care - Cardiovascular-2025 (France)
- Pharma and Biotech Financial Outlook - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharma and Biotech Financial Outlook - Future Pharma 2025 (Netherlands)
- Pharma Companies - Pharma Europe 2025 (Italy)
- Pharma Market Research - MedTech-2024 (Switzerland)
- Pharmaceutical Analysis - Future Pharma 2025 (Netherlands)
- Pharmaceutical Analysis - Pharmatech 2025 (Canada)
- Pharmaceutical Analysis: Analytical Methods - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical and healthcare Industry - Future Pharma 2025 (Netherlands)
- Pharmaceutical Biotechnology - Pharma Europe 2025 (Italy)
- Pharmaceutical Chemistry - BIOSIMILARS-2024 (Indonesia)
- Pharmaceutical Chemistry - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical Chemistry - Pharma Europe 2025 (Italy)
- Pharmaceutical Chemistry - Future Pharma 2025 (Netherlands)
- Pharmaceutical Chemistry - Pharmatech 2025 (Canada)
- Pharmaceutical Engineering - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Engineering - Pharma Europe 2025 (Italy)
- Pharmaceutical Formulation Advances - Clinical Trials Congress-2025 (France)
- Pharmaceutical Formulations - Pharma Europe 2025 (Italy)
- Pharmaceutical Industry - Pharmatech 2025 (Canada)
- Pharmaceutical Industry and Market Trends - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Pharmaceutical Manufacturing - BIOSIMILARS-2024 (Indonesia)
- Pharmaceutical Manufacturing and Pharmacoeconomics - MedTech-2024 (Switzerland)
- Pharmaceutical Manufacturing, Scale Up and Tech transfer - MedTech-2024 (Switzerland)
- Pharmaceutical Marketing - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceutical Microbiology - Pharma Europe 2025 (Italy)
- Pharmaceutical Microbiology and Biotechnology - PHARMA CONFERENCE-2025 (Czech Republic)
- Pharmaceutical Nanotechnology - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Nanotechnology - Pharma Europe 2025 (Italy)
- Pharmaceutical Packaging and Logistics - MedTech-2024 (Switzerland)
- Pharmaceutical Process Validation - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Research and Development - Pharmatech 2025 (Canada)
- Pharmaceutical Science - Pharmatech 2025 (Canada)
- Pharmaceutical Sciences - Clinical-Trials-2024 (Canada)
- Pharmaceutical Sciences - MedTech-2024 (Switzerland)
- Pharmaceutical sciences - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Sciences - Pharma Europe 2025 (Italy)
- Pharmaceutical Supply Chain Optimization - PHARMACEUTICAL SCIENCES 2025 (France)
- Pharmaceutical Technology - Clinical Trials Congress-2025 (France)
- Pharmaceuticals and Cosmetics - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmaceuticals and Drug Delivery Systems Using Nanotechnology - Drug Safety 2024 (France)
- Pharmaceuticals and Nutraceuticals - PHARMAKON 2025 (Spain)
- Pharmaceutics - Pharma Europe 2025 (Italy)
- Pharmaceutics & Pharmacotherapeutics - Future Pharma 2025 (Netherlands)
- Pharmaceutics and Pharmacotherapeutics - Pharmatech 2025 (Canada)
- Pharmacists Role in Patient Safety - Pharmatech 2025 (Canada)
- Pharmacodynamics - PHARMAKON 2025 (Spain)
- Pharmacoeconomics - MedTech-2024 (Switzerland)
- Pharmacogenetics - Personalizedmedicine-2024 (Switzerland)
- Pharmacogenetics & Pharmacogenomics - PHARMA CONFERENCE-2025 (Czech Republic)
- Pharmacogenetics and Personalized Medicine - Pharmacology-2024 (France)
- Pharmacogenomics - Drug Safety 2024 (France)
- Pharmacogenomics - Personalizedmedicine-2024 (Switzerland)
- Pharmacogenomics - BIOSIMILARS-2024 (Indonesia)
- Pharmacogenomics - PHARMAKON 2025 (Spain)
- Pharmacogenomics and Pharmacoepidemiology - MedTech-2024 (Switzerland)
- Pharmacogenomics in Cardiovascular Medicine - Cardiovascular-2025 (France)
- Pharmacognosy - Pharma Europe 2025 (Italy)
- Pharmacognosy - PHARMAKON 2025 (Spain)
- Pharmacokinetics - PHARMAKON 2025 (Spain)
- Pharmacokinetics and Pharmacodynamics - Pharmacology-2024 (France)
- Pharmacokinetics and Pharmacodynamics - Pharmaceutica-2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmacokinetics and Pharmacodynamics - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Pharmacokinetics and Pharmacodynamics in Cardiology - Cardiovascular-2025 (France)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics Resistance 2024 (Canada)
- Pharmacological Advances and Drug Development - NURSING PHARMACOLOGY 2024 (Netherlands)
- Pharmacological Approaches to Myocardial Ischemia - Cardiovascular-2025 (France)
- Pharmacological Management of Cardiovascular Risk Factors - Cardiovascular-2025 (France)
- Pharmacological Sciences - Pharma Europe 2025 (Italy)
- Pharmacology - Drug Safety 2024 (France)
- Pharmacology - Pharmatech 2025 (Canada)
- Pharmacology & Toxicology - Antibiotics Resistance 2024 (Canada)
- Pharmacology and Toxicology - MedTech-2024 (Switzerland)
- Pharmacology and Toxicology - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Pharmacology of Addiction and Substance Abuse - Pharmacology-2024 (France)
- Pharmacology of Aging and Geriatric Medicine - Pharmacology-2024 (France)
- Pharmacology of Antimicrobial Resistance - Pharmacology-2024 (France)
- Pharmacology of Cancer Immunotherapy - Pharmacology-2024 (France)
- Pharmacology of Cardiovascular Therapeutics - Pharmacology-2024 (France)
- Pharmacology of Neurodegenerative Disorders - Pharmacology-2024 (France)
- Pharmacology of Nutraceuticals and Dietary Supplements - Pharmacology-2024 (France)
- Pharmacology of Pain Management and Analgesia - Pharmacology-2024 (France)
- Pharmacology of Rare Diseases - Pharmacology-2024 (France)
- Pharmacology of Respiratory Diseases: - Pharmacology-2024 (France)
- Pharmacovigilance and Drug Safety - Clinical-Trials-2024 (Canada)
- Pharmacovigilance and Drug Safety - PHARMA CONFERENCE-2025 (Czech Republic)
- Pharmacovigilance in the Era of Big Data - Pharmacology-2024 (France)
- Pharmacy Development Services - Pharma Europe 2025 (Italy)
- Pharmacy Education and Practice - PHARMACEUTICAL SCIENCES 2025 (France)
- Photochemistry and Phytopharmaceuticals - PHARMAKON 2025 (Spain)
- Phytochemistry - Natural Products 2024 (Italy)
- Population Health - Personalizedmedicine-2024 (Switzerland)
- Post-Marketing Surveillance Insights - Clinical Trials Congress-2025 (France)
- Post-Trial Closed Communities - Clinical Trials Congress-2025 (France)
- Precision Medicine - Personalizedmedicine-2024 (Switzerland)
- Precision Medicine and Pharmacogenomics - NURSING PHARMACOLOGY 2024 (Netherlands)
- Public Health and Community Nursing - NURSING PHARMACOLOGY 2024 (Netherlands)
- Purpose and Principles of GMP - PHARMACEUTICAL SCIENCES 2025 (France)
- QC & QA: Quality control and Quality assurance - MedTech-2024 (Switzerland)
- Quality by design(QbD) approach - MedTech-2024 (Switzerland)
- Quality Control and Regulatory Considerations in Drug Delivery Systems - Pharmaceutica-2025 (Canada)
- R&D Advancement: Road to New Medicines - PHARMACEUTICAL SCIENCES 2025 (France)
- Radiation-based medicines and biotherapy - Drug Safety 2024 (France)
- Rational Design of Non-Oral Drugs - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Rational Drug Design and Molecular Modeling - PHARMA CONFERENCE-2025 (Czech Republic)
- Real-World Evidence in Clinical Trials - Pharma Europe 2025 (Italy)
- Recent Advancements in Medicinal Pharma - PHARMA MEDICINAL CHEMISTRY 2025 (Canada)
- Reformulation Research - Drug Safety 2024 (France)
- Regenerative Medicine and Tissue Engineering - Drug Delivery-2024 (France)
- Regulatory Affairs and Drug Safety - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Regulatory Affairs and Intellectual Property Rights - Future Pharma 2025 (Netherlands)
- Regulatory Affairs and Quality Assurance in Pharmaceutics - Pharmaceutica-2025 (Canada)
- Regulatory Authority Compliance - MedTech-2024 (Switzerland)
- Regulatory Considerations in Drug Development - Drug Delivery-2024 (France)
- Regulatory Requirements for Pharmaceuticals - PHARMACEUTICAL SCIENCES 2025 (France)
- Regulatory Updates on Biosimilars - Eurobiosimilars 2025 (France)
- Research and development in pharmaceuticals - Drug Safety 2024 (France)
- Research and Trials on Oncology and AIDS - Clinical-Trials-2024 (Canada)
- Role of Gut Microbiome in Cardiovascular Health - Cardiovascular-2025 (France)
- Role of Inflammation in Cardiovascular Diseases - Cardiovascular-2025 (France)
- Safety of drugs and pharmacovigilance - Drug Safety 2024 (France)
- Smart Drug Delivery Systems - Pharmatech 2025 (Canada)
- Smart Polymers for Drug Delivery - Pharmaceutica-2025 (Canada)
- Sustainability and Global Health Biotechnology - Biotech-2025 (France)
- Synthetic and Bioorganic Chemistry - PHARMACEUTICAL CHEMISTRY 2025 (Italy)
- Targeted Drug Delivery and Controlled Release Systems - PHARMA CONFERENCE-2025 (Czech Republic)
- Targeted Therapies - Personalizedmedicine-2024 (Switzerland)
- Targeted Therapies in Cardiovascular Regeneration - Cardiovascular-2025 (France)
- Targeting the Renin-Angiotensin-Aldosterone System (RAAS) - Cardiovascular-2025 (France)
- Technologies for Formulation - Drug Safety 2024 (France)
- Technology in Pharma Sciences - MedTech-2024 (Switzerland)
- Telemedicine - Personalizedmedicine-2024 (Switzerland)
- The BBB for drug delivery - Drug Safety 2024 (France)
- The Future of Pharma R&D - Future Pharma 2025 (Netherlands)
- The Next Generation Approach of Antibiotics - Antibiotics Resistance 2024 (Canada)
- Therapeutic Drug Transporters - Drug Safety 2024 (France)
- Translational Research - Personalizedmedicine-2024 (Switzerland)
- Translational Research in Pharmacology and Therapeutics - NURSING PHARMACOLOGY 2024 (Netherlands)
- USFDA Approved Biosimilars - Eurobiosimilars 2025 (France)
- Vaccine Delivery Systems - Pharmaceutica-2025 (Canada)
- Vaccine Design and Drug Design - PHARMA CONFERENCE-2025 (Czech Republic)
- Vascular Pharmacology: Focus on Endothelial Dysfunction - Cardiovascular-2025 (France)
- Wearable Drug Delivery Systems - PHARMA CONFERENCE-2025 (Czech Republic)